Skeleton and Joint Degeneration with Aging

骨骼和关节随衰老而退化

基本信息

  • 批准号:
    10326799
  • 负责人:
  • 金额:
    $ 187.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-15 至 2025-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Decreased mobility significantly increases the risk of many chronic diseases leading to an acceleration of the normal aging process. Skeletal degeneration, particularly of the spine and joints, are among the most prevalent diseases leading to a decline in mobility and to frailty. Frailty, defined as a state of decreased physiologic reserve, often develops with aging and influences a person’s ability to compensate for the additional burden of disease. With development of frailty, the natural homeostatic reserve is reduced and the ability of the body to compensate for perturbations is reduced. Degeneration of the spine and joints can substantially accelerate development of frailty; however, the underlying pathophysiology of this degeneration in aging and the development and progression of resulting low back pain (LBP) and osteoarthritis (OA) is not well understood. There is no disease- modifying treatment for either, largely due to the lack in the understanding of pathophysiology of pain and the unique cellular signaling changes among OA subtypes. LBP commonly results from degeneration of the amphiarthrodial spinal joints, with pain correlating most strongly with changes in vertebral endplate morphology. Degeneration of diarthrodial joints is a set of diverse processes that are frequently lumped together under the umbrella term “osteoarthritis” but represent a heterogeneous disease process. Osteoclasts (OC) in both vertebral endplates and subchondral bone undergo senescence during aging to generate porous sclerotic endplates, uncoupled remodeling in subchondral bone, and senescent OC secrete Netrin-1 to induce axonal extrusion and innervation that potentially lead to pain. Therefore, we hypothesize that porous sclerotic endplates and uncoupled remodeling of subchondral bone by senescent OC lead to skeletal joint degeneration and pain, severely limiting mobility and increasing frailty to accelerate aging. In Project 1, we will investigate how endplate porosity with aging induces spinal degeneration and sensory innervation to result in LBP. In Project 2, we will investigate the mechanism of the translational application of intermittent parathyroid hormone injection (iPTH) – increased intervertebral disc (IVD) volume to spinal degeneration and reduce endplate nerve innervation and LBP by remodeling of porous sclerotic endplates. In Projects 3, we will characterize the mechanism of cellular senescence in two different subtypes of OA: non-traumatic OA that is orchestrated by senescence of pre-OC. Together, these 3 projects, supported by common Administrative and Biostatistics (Core A) and In Vivo Model and Histology (Core B) Cores, will result in nuanced understanding of the pathophysiology of joint and spinal degeneration associated with aging and will provide foundational mechanistic insights for potential therapeutic targets.
项目总结/摘要 活动能力的下降大大增加了许多慢性疾病的风险,导致疾病的加速。 正常的衰老过程。骨骼退化,特别是脊柱和关节的退化,是最普遍的 导致活动能力下降和身体虚弱的疾病。虚弱,定义为生理储备减少的状态, 通常随着年龄的增长而发展,并影响一个人补偿疾病额外负担的能力。 随着虚弱的发展,自然的自我平衡储备减少,身体的补偿能力下降, 因为扰动减少了。脊柱和关节的退化可以大大加速 然而,这种退化在衰老和发育中的潜在病理生理学, 引起的下背痛(LBP)和骨关节炎(OA)的进展尚不清楚。没有疾病- 修改治疗,主要是由于缺乏对疼痛的病理生理学的理解, OA亚型之间独特的细胞信号传导变化。 腰椎间盘突出症通常是由椎关节退变引起的,与疼痛密切相关 椎体终板形态改变。关节退行性变是一系列不同的过程 这些疾病经常被统称为"骨关节炎",但代表了一种异质性的骨关节炎。 疾病过程。椎体终板和软骨下骨中的破骨细胞(OC)经历衰老 在老化过程中产生多孔软骨终板,在软骨下骨中进行非偶联重塑, OC分泌Netrin-1诱导轴突挤出和神经支配,可能导致疼痛。所以我们 假设多孔软骨终板和软骨下骨非偶联重建 衰老的OC导致骨骼关节退化和疼痛,严重限制了活动性, 加速衰老的弱点在项目1中,我们将研究终板多孔性如何随着年龄的增长而诱导脊柱 变性和感觉神经支配导致LBP。在项目2中,我们将研究 间歇性甲状旁腺激素注射(iPTH)的转化应用-椎间盘(IVD)增加 通过重建多孔性骨质减少终板神经支配和LBP 终板在项目3中,我们将描述两种不同亚型的细胞衰老机制, OA:由前OC衰老引起的非创伤性OA。这三个项目由 将产生通用管理和生物统计学(核心A)和体内模型和组织学(核心B)核心 在微妙的理解与衰老和意志有关的关节和脊柱退化的病理生理学 为潜在的治疗靶点提供基础机制见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xu Cao其他文献

Xu Cao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xu Cao', 18)}}的其他基金

Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging
TLR2 唾液酸化诱导衰老过程中破骨细胞融合和 Th 17 分化
  • 批准号:
    10430544
  • 财政年份:
    2022
  • 资助金额:
    $ 187.79万
  • 项目类别:
Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging
TLR2 唾液酸化诱导衰老过程中破骨细胞融合和 Th 17 分化
  • 批准号:
    10650877
  • 财政年份:
    2022
  • 资助金额:
    $ 187.79万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10326800
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Endplate Sensory Innervations for LBP
LBP 的终板感觉神经支配
  • 批准号:
    10556415
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Endplate Sensory Innervations for LBP
LBP 的终板感觉神经支配
  • 批准号:
    10326802
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Skeleton and Joint Degeneration with Aging
骨骼和关节随衰老而退化
  • 批准号:
    10556410
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Endplate Sensory Innervations for LBP
LBP 的终板感觉神经支配
  • 批准号:
    10090196
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10556411
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Skeleton and Joint Degeneration with Aging
骨骼和关节随衰老而退化
  • 批准号:
    10090193
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10090194
  • 财政年份:
    2021
  • 资助金额:
    $ 187.79万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 187.79万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了